Informa
RNA Leaders USA
RNAのブレイクスルー、ケーススタディ、パートナーシップ
2026年9月23-25日 米国、マサチューセッツ州ボストン、Hynes Convention Center
Key Sessions
Malgorzata Gonciarz
Presentation: Utilising External Innovation pathways for accelerated clinical transition of RNA Therapies
Novartis
Chandra Vargeese, PhD
Presentation: RNAi Targeting INHBE for Obesity and Metabolic Disorders: Genetic Validation, Mechanism, and Clinical Translation
Wave Life Science
Britton Jimenez
Presentation: Scaling siRNA for Real World Use: Why ECO Synthesis Changes the Equation
Codexis
Anders Näär
Panel: The role of AI in RNA - Drug Discovery, Rare Diseases and Clinical Applications
UC Berkeley

Wednesday, September 23 - EST (Eastern Time, UTC-05:00

Wednesday, September 23 - EST (Eastern Time, UTC-05:00
8:00am - 9:00am60 mins
Registration
    9:00am - 10:30am90 mins
    RNA Leaders Business Forum
    Workshop 1: RNA Therapeutics - Valuation Workshop
    • Renee Williams - Founder and Managing Partner, Williams Biotech Consulting, LLC
    • Jeff Raphael - Founder & Managing Partner, OmniScope Partners
    9:00am - 10:30am90 mins
    RNA Leaders Technical Track
    Workshop 2 - Targeted delivery of Oligos & mRNA
    • Haig Aghajanian - Co-Founder & Head of Research, Capstan Therapeutics
    10:30am - 11:00am30 mins
    RNA Leaders Business Forum
    Morning Break
      10:30am - 11:00am30 mins
      RNA Leaders Technical Track
      Morning Break
        11:00am - 12:30pm90 mins
        RNA Leaders Business Forum
        Workshop 3 - RNA Leaders CEO Forum
          11:00am - 12:30pm90 mins
          RNA Leaders Technical Track
          Workshop 4 - Regulatory and CMC Innovation
          • Vinita Doshi - Senior Scientist, Intellia
          • Vega Shetty - Scientist, Intellia
          • Mayurbhai Patel - Senior Director Chemistry Director & CMC, Judo Bio
          12:30pm - 2:00pm90 mins
          Lunch
            2:00pm - 2:15pm15 mins
            Keynote Session
            RNA Leaders Welcome & Chair Opening Address
            • Jade Osei-Tutu - Head of RNA Leaders, Informa Connect
            2:15pm - 2:45pm30 mins
            Keynote Session
            Presentation: Utilising External Innovation pathways for accelerated clinical transition of RNA Therapies
            • Malgorzata Gonciarz - Global Head xRNA Therapeutics, Novartis
            2:45pm - 3:30pm45 mins
            Keynote Session
            Panel: M&A in the RNA Therapeutics Landscape: Insights, Challenges, and Strategies for Success
            • Renee Williams - Founder and Managing Partner, Williams Biotech Consulting, LLC
            3:30pm - 4:00pm30 mins
            Keynote Session
            Presentation: RNAi Targeting INHBE for Obesity and Metabolic Disorders: Genetic Validation, Mechanism, and Clinical Translation
            • Chandra Vargeese, PhD - Chief Technology Officer, Wave Life Science
            4:00pm - 4:30pm30 mins
            Keynote Session
            Presentation: Scaling siRNA for Real World Use: Why ECO Synthesis Changes the Equation
            • Britton Jimenez - SVP, Sales and Marketing, Codexis
            4:30pm - 5:15pm45 mins
            Keynote Session
            Panel: The role of AI in RNA - Drug Discovery, Rare Diseases and Clinical Applications
            • Anders Näär - Professor of Metabolic Biology, UC Berkeley
            • Tamar Grossman - CEO, La Jolla Labs
            • Edward Miracco, Ph.D. - Director, RNA Chemical Biology/External Technology Investments, Moderna, Inc.
            • Crystal Jin - CEO, Bound Therapeutics
            5:15pm - 6:45pm90 mins
            Drinks Reception

              * 不測の事態により、事前の予告なしにプログラムが変更される場合があります。

              NextThursday, September 24